Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| WES-2 | HIV2ES | U.S. | 1992 | HIV1 | B | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | NA |
| 2 | DDI | 61 |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| K70R, L74V, T215Y | V35I, D123E, S162C, D177E, R211K |
| >HIV2ES| codons 29-230 EKIKALIEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTRWRKVVDFRELNKRTQDFW EVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKEFRKYTAFTIPSINNETPGIRYQYNV LPQGWKGSPAIFQCSMTKILEPFRKQNPEIVIYQYMDDLYVGSDLEIGQHRTKIEELRQH LLKWGFYTPDKKHQKEPPFLWM |
References
| Author | Title | Citation |
| Naugler, WE | T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. | J Infect Dis, 2002 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |